ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Peiwen Yang
Matched on ORCID iD 0000-0003-2929-1334; OpenAlex author ID A5028145641. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2022: 2 papers · 2023: 1 paper · 2024: 3 papers · 2025: 2 papers · 2026: 3 papers
Papers 11
- Role of PTK6 in the diagnosis, prognosis, and immune infiltration of pancreatic cancer based on evidence from bioinformatics analysis and experimental validati… Co-author DOI 10.1007/s12672-026-05115-9↗
- Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ERK/DRP1 Pathway. Co-author DOI 10.1142/s0192415x26500606↗
- Bufalin Suppresses Pancreatic Ductal Adenocarcinoma Through ER Stress-Ferroptosis Crosstalk Associated with IP3R-Linked Ca2+ Dysregulation and ATF3/SLC7A11 Reg… Co-author DOI 10.3390/ijms27104373↗
- Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.phymed.2025.157048↗
- Modified Sijunzi Decoction Inhibits Pancreatic Cancer Progression and Improves Immune Suppression: Network Pharmacology and Experimental Validation. Co-author DOI 10.2147/dddt.s520390↗
- Novel silicene-mesoporous silica nanoparticles conjugated gemcitabine induced cellular apoptosis via upregulating NF-κB p65 nuclear translocation suppresses pa… Co-author DOI 10.1088/1361-6528/ad312a↗
- "Huanglianjiedu Decoction" Against Pancreatic Adenocarcinoma Proliferation of by Downregulating the PI3K/AKT/mTOR and MAPK/ERK1/2 Signaling Pathways. Co-author DOI 10.1177/2515690x241291381↗
- Cynanchum paniculatum (Bunge) Kitag. ex H.Hara inhibits pancreatic cancer progression by inducing caspase-dependent apoptosis and suppressing TGF-β-mediated ep… Co-author DOI 10.3389/fphar.2024.1284371↗
- Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphorylation. Co-author DOI 10.1186/s10020-023-00648-z↗
- Integrating network pharmacology and experimental models to investigate the efficacy of QYHJ on pancreatic cancer. Co-author DOI 10.1016/j.jep.2022.115516↗
- Fibroblast activation protein-based theranostics in pancreatic cancer. First author DOI 10.3389/fonc.2022.969731↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chien‐shan Cheng · 6 shared papers, 2022–2024 · strength 1.35
- Paper Novel silicene-mesoporous silica nanoparticles conjugated gemcitabine induced cellular apoptosis via upregulating NF-κB… DOI 10.1088/1361-6528/ad312a↗
- Paper "Huanglianjiedu Decoction" Against Pancreatic Adenocarcinoma Proliferation of by Downregulating the PI3K/AKT/mTOR and M… DOI 10.1177/2515690x241291381↗
- Paper Cynanchum paniculatum (Bunge) Kitag. ex H.Hara inhibits pancreatic cancer progression by inducing caspase-dependent apo… DOI 10.3389/fphar.2024.1284371↗
- Waimei Si · 4 shared papers, 2025–2026 · strength 1.18
- Paper Bufalin Suppresses Pancreatic Ductal Adenocarcinoma Through ER Stress-Ferroptosis Crosstalk Associated with IP3R-Linked… DOI 10.3390/ijms27104373↗
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.phymed.2025.157048↗
- Xin Li · 4 shared papers, 2025–2026 · strength 1.18
- Paper Bufalin Suppresses Pancreatic Ductal Adenocarcinoma Through ER Stress-Ferroptosis Crosstalk Associated with IP3R-Linked… DOI 10.3390/ijms27104373↗
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.phymed.2025.157048↗
- Linjie Ruan · 4 shared papers, 2023–2026 · strength 1.09
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.phymed.2025.157048↗
- Paper Modified Sijunzi Decoction Inhibits Pancreatic Cancer Progression and Improves Immune Suppression: Network Pharmacology… DOI 10.2147/dddt.s520390↗
- Zhen Chen · 4 shared papers, 2022–2026 · strength 1.01
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Modified Sijunzi Decoction Inhibits Pancreatic Cancer Progression and Improves Immune Suppression: Network Pharmacology… DOI 10.2147/dddt.s520390↗
- Paper Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphor… DOI 10.1186/s10020-023-00648-z↗
- Juying Jiao · 4 shared papers, 2022–2026 · strength 1.00
- Paper Role of PTK6 in the diagnosis, prognosis, and immune infiltration of pancreatic cancer based on evidence from bioinform… DOI 10.1007/s12672-026-05115-9↗
- Paper "Huanglianjiedu Decoction" Against Pancreatic Adenocarcinoma Proliferation of by Downregulating the PI3K/AKT/mTOR and M… DOI 10.1177/2515690x241291381↗
- Paper Paired protein kinases PRKCI-RIPK2 promote pancreatic cancer growth and metastasis via enhancing NF-κB/JNK/ERK phosphor… DOI 10.1186/s10020-023-00648-z↗
- Yuan Zhang · 3 shared papers, 2025–2026 · strength 0.87
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.phymed.2025.157048↗
- Paper Modified Sijunzi Decoction Inhibits Pancreatic Cancer Progression and Improves Immune Suppression: Network Pharmacology… DOI 10.2147/dddt.s520390↗
- He Ba · 3 shared papers, 2025–2026 · strength 0.87
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.phymed.2025.157048↗
- Paper Modified Sijunzi Decoction Inhibits Pancreatic Cancer Progression and Improves Immune Suppression: Network Pharmacology… DOI 10.2147/dddt.s520390↗
- Shu Dong Ma · 3 shared papers, 2022–2024 · strength 0.70
- Paper Novel silicene-mesoporous silica nanoparticles conjugated gemcitabine induced cellular apoptosis via upregulating NF-κB… DOI 10.1088/1361-6528/ad312a↗
- Paper "Huanglianjiedu Decoction" Against Pancreatic Adenocarcinoma Proliferation of by Downregulating the PI3K/AKT/mTOR and M… DOI 10.1177/2515690x241291381↗
- Paper Integrating network pharmacology and experimental models to investigate the efficacy of QYHJ on pancreatic cancer. DOI 10.1016/j.jep.2022.115516↗
- Lianyu Chen · 2 shared papers, 2024 · strength 0.54
- Paper Novel silicene-mesoporous silica nanoparticles conjugated gemcitabine induced cellular apoptosis via upregulating NF-κB… DOI 10.1088/1361-6528/ad312a↗
- Paper "Huanglianjiedu Decoction" Against Pancreatic Adenocarcinoma Proliferation of by Downregulating the PI3K/AKT/mTOR and M… DOI 10.1177/2515690x241291381↗
- Xiaoyan Zhu · 2 shared papers, 2022–2026 · strength 0.48
- Paper Bufalin Suppresses Pancreatic Ductal Adenocarcinoma Through ER Stress-Ferroptosis Crosstalk Associated with IP3R-Linked… DOI 10.3390/ijms27104373↗
- Paper Integrating network pharmacology and experimental models to investigate the efficacy of QYHJ on pancreatic cancer. DOI 10.1016/j.jep.2022.115516↗
- Panling Xu · 2 shared papers, 2022–2024 · strength 0.42
- Paper "Huanglianjiedu Decoction" Against Pancreatic Adenocarcinoma Proliferation of by Downregulating the PI3K/AKT/mTOR and M… DOI 10.1177/2515690x241291381↗
- Paper Integrating network pharmacology and experimental models to investigate the efficacy of QYHJ on pancreatic cancer. DOI 10.1016/j.jep.2022.115516↗
- Shu-Lin Yu · 1 shared paper, 2026 · strength 0.36
- Yue Fan · 1 shared paper, 2026 · strength 0.36
- Fang Wang · 1 shared paper, 2026 · strength 0.36
- Zhen Chen · 1 shared paper, 2026 · strength 0.32
- Lixia Yi · 1 shared paper, 2026 · strength 0.30
- Zhen Chen · 1 shared paper, 2025 · strength 0.28
- Yuhang Chen · 1 shared paper, 2024 · strength 0.28
- Jingxian Chen · 1 shared paper, 2024 · strength 0.23
- Lan Zheng · 1 shared paper, 2024 · strength 0.23
- Jiabin Jin · 1 shared paper, 2024 · strength 0.23
- Fengjiao Wang · 1 shared paper, 2023 · strength 0.22
- Shaoli Song · 1 shared paper, 2022 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.